News

News
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story
Partner news

CVRx Raises $50 Million in New Equity Financing

Read full story
Partner news

Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Read full story
Partner news

Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform

Read full story
Partner news

HistoSonics Announces $40 Million Financing

Read full story
Partner news

resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology

Read full story
Partner news

ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes

Read full story
Partner news

Inivata Announces Strategic Collaboration and Investment from NeoGenomics

Read full story
Partner news

Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics

Read full story
Partner news

Philogen Announces Options Exercise by Janssen

Read full story
Partner news

RefleXion Raises $100 Million for Cancer Treatment Commercialization

Read full story
Partner news

Fate Therapeutics Announces Worldwide Collaboration with Janssen for Novel iPSC-derived Cell-based Cancer Immunotherapies

Read full story
Partner news

Legend Biotech Raises $150.5 Million in Series A Preferred Financing To Advance its Oncology Pipeline and Platform

Read full story
Partner news

OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing

Read full story
Partner news

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Read full story